Dana P. Goldman is University Professor of Public Policy, Pharmacy, and Economics and Founding Director of the Schaeffer Institute for Public Policy & Government Service at the University of Southern California. The Institute houses the Schaeffer Center for Health Policy & Economics—recognized as one of the most influential health economics programs globally. Dr. Goldman also serves as special advisor to the Provost and previously served as Dean of the USC Price School of Public Policy.
He is author or co-author of more than 400 articles (27,000+ citations) spanning economics, medicine, and public policy. He pioneered a “Netflix model” for the chronically ill and has been awarded more than $150 million in research support from the National Institutes of Health, private industry, and philanthropic sources. He has served as a policy advisor to the Congressional Budget Office, California Institute of Regenerative Medicine, Covered California, Fred Hutchinson Cancer Institute, GRAIL, Edwards Lifesciences, and the Mark Cuban Cost Plus Drug Company. He served as a board member of Price Philanthropies, American Society of Health Economists, and ISPOR. His research is regularly featured in the New York Times, Wall Street Journal, Washington Post, STAT, The Economist, NBC Nightly News, PBS NewsHour, CNN, NPR, and other media.
In 2024, USC appointed Dr. Goldman a University Professor to “recognize his decades of excellence as a policy leader and champion of interdisciplinary collaboration.” He is an elected member of the National Academy of Medicine, National Academy of Social Insurance, and National Academy of Public Administration — three of his field’s highest honors. He is a recipient of the USC Associates Award, Alice Hersh Emerging Leader Award, MetLife Silver Scholar Award, NIHCM Research Award, Mellon Mentoring Award, and Robert Biller Outstanding Faculty Award, among other distinctions.
Dr. Goldman is a committed mentor to students and faculty. He founded and led USC’s Resource Center for Minority Aging Research for 8 years with support from NIH. Past trainees include faculty at Stanford, Harvard, Duke, UCLA, UCSF, USC, Tufts, University of Pennsylvania, and Vanderbilt. He co-founded two companies (EntityRisk and Precision Health Economics) to transform the way companies conduct health economics and outcomes research.
Dr. Goldman is a research associate at the National Bureau for Economic Research. He graduated from Cornell University summa cum laude and earned a PhD in economics from Stanford University.
